Pfizer vacine set for EU aproval

Pfizer and BioNTech asked for aproval of their vaccine in EU and it could be done before end of the year. UK bypassed EU regulation and might have it done even quicker with US FDA not far behind. In the last stage of trials where vaccine wastested on 44000 people, it showed 95% success preventing symphomatic cases. Pfizer also stated that they are ready to start shipping vaccine just hours after its aproval, so we will be able to see first vacination before end of the year. With Moderna as only competing firm to be able to make aproval before end of the year we can expect Pfizer and BioNTech share price rise. (Kresge, Bloomberg)

4 views0 comments

Recent Posts

See All
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • YouTube

Risk Warning:
Past performance of an investment is no guide to its performance in the future. Investments, or income from them, can go down as well as up. You may not necessarily get back the amount you invested. All opinions, news, analysis, prices or other information contained in our communication and on our website, are provided as general market commentary and do not constitute investment advice, nor a solicitation or recommendation to buy or sell any financial instruments or other financial products or services.

© 2021 Trade Forum Philippines. All rights reserved.